Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ENO3 |
| Upstream (Parents) |
|---|
| (<<) CYP1A2 → ENO3 |
| (<<) CYP4F2 → ENO3 |
| (<<) FGFR2 → ENO3 |
| (<<) FUT2 → ENO3 |
| (<<) G0S2 → ENO3 |
| (<<) GRHPR → ENO3 |
| (<<) HK1 → ENO3 |
| (<<) HSD11B1 → ENO3 |
| (<<) HYAL1 → ENO3 |
| (<<) MMP19 → ENO3 |
| (<<) PCK2 → ENO3 |
| (<<) RDH16 → ENO3 |
| (<<) TPM1 → ENO3 |
| (<<) TSPAN3 → ENO3 |
| Downstream (Children) |
|---|
| ENO3 → ANGPTL4 (>>) |
| ENO3 → CHI3L1 (>>) |
| ENO3 → COX6A2 (>>) |
| ENO3 → EGFR (>>) |
| ENO3 → FZD7 (>>) |
| ENO3 → FZD8 (>>) |
| ENO3 → HES1 (>>) |
| ENO3 → HMGCR (>>) |
| ENO3 → MUC2 (>>) |
| ENO3 → NEDD4 (>>) |
| ENO3 → PPIB (>>) |
| ENO3 → PRKX (>>) |
| ENO3 → SMAD2 (>>) |
| ENO3 → TNFAIP3 (>>) |
| ENO3 → TNFRSF11A (>>) |
| ENO3 → TPSG1 (>>) |
| ENO3 → ZNF215 (>>) |
